Dr. Kyle J. Jackson, D.O.
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- University of North Texas Hsc, College of Osteopathic Med (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 571
Licensed in Texas since 2016, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: University of North Texas Hsc, College of Osteopathic Med
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
TX license Q6851 (first issued 2016; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christus Mother Frances Hospital Tyler, TX
- Christus Good Shepherd Medical Center Longview, TX
- Christus Mother Frances Hospital Sulphur Springs Sulphur Springs, TX
- Christus Mother Frances Hospital- Jacksonville Jacksonville, TX
- Christus Mother Frances Hospital- Winnsboro Winnsboro, TX
Medical groups
- Christus Trinity Clinic Texas (1,540 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 571
- Services billed
- 2,436
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 674 | 405 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 159 | 88 |
| Established patient office or other outpatient visit, 20-29 minutes | 129 | 117 |
| New patient office or other outpatient visit, 45-59 minutes | 70 | 70 |
| Insertion of needle into vein for collection of blood sample | 43 | 31 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 36 | 18 |
| Hemoglobin a1c level | 29 | 29 |
| New patient office or other outpatient visit, 30-44 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Tyler, TX | 962 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Tyler, TX | 598 |
| Jardiance (empagliflozin) Other prescribers in Tyler, TX | 520 |
| Ozempic (semaglutide) Other prescribers in Tyler, TX | 478 |
| Metformin Hcl Other prescribers in Tyler, TX | 323 |
| Mounjaro (tirzepatide) Other prescribers in Tyler, TX | 320 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Tyler, TX | 299 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Tyler, TX | 277 |
| Trulicity (dulaglutide) Other prescribers in Tyler, TX | 231 |
| Glimepiride Other prescribers in Tyler, TX | 229 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 4 payments worth $183 in total to this clinician.
| Medtronic, Inc. | $62.38 |
|---|---|
| Cequr Corporation | $57.07 |
| Sequel Med Tech, LLC | $38.96 |
| Amgen Inc. | $24.26 |
| Food and Beverage | $158 |
|---|---|
| Education | $24.26 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Oct 2, 2025 | Education TEPEZZA · Inflammation/Rare Disease · in-kind | $24.26 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.